The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient
CJC Pediatr Congenit Heart Dis
.
2023 Nov 3;3(1):11-13.
doi: 10.1016/j.cjcpc.2023.10.011.
eCollection 2024 Feb.
Authors
Sarah Grütter
1
,
David Haefliger
2
,
Grégoire Wuerzner
3
,
Patrick Yerly
1
,
Judith Bouchardy
1
,
Tobias Rutz
1
Affiliations
1
Service of Cardiology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
2
Division of Clinical Pharmacology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
3
Division of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
PMID:
38544879
PMCID:
PMC10964255
DOI:
10.1016/j.cjcpc.2023.10.011
No abstract available
Publication types
Case Reports